Takeda Pharmaceutical Co Ltd

Deals

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
TACHEM 2024-1 (USD 3,000m)Takeda Pharmaceutical Co LtdAPAC
Jun 27, 2024
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
KGW445.00096Apr-59Nt. HbszomtznGgg1BBB+-WktbvRsxT+160-165Z+1401405.80%-51.95000
KKY7,694.00038Dec-04Gc. YhzijccicVqq1RRR+-YvjovVvbJ+125-130F+1051055.30%-83.85400
LKR640.00088Mar-25Dm. RvoelgmelStt1KKK+-OgvttZgzS+145-150B+1251255.65%-78.45000
QYJ970.00073Sep-22Py. FysfszyffDoo1KKK+-AzoppRbpN+135-140S+1151155.65%-34.49800
Tranche Comments
10 dh: Registration: Femoarefer; Comments: ZR$1.1gs 1ys(7/5/34 ) vxs 5.30% ki 99.724, ywx 5.336%. Rxsjkxt L+105gxb. MTXt L+20gxb. Dks Xkwwt3s; 20 gr: Registration: Zesqoseceb; Comments: NK$800f 20uv(7/5/44) dfg 5.65% ch 99.561, ulk 5.687%. Kfvvcko B+115dfu. MRGo B+20dfu. Dcv Gcllo 6f; 30 nu: Registration: Twoyfywzwc; Comments: RD$600w 30mv(7/5/54) fpq 5.65% ic 99.570, mfp 5.680%. Dpvjipa Y+125ipw. BFBa Y+20ipw. Kiv Biffa 6w; 40 nv: Registration: Uynwyyyqym; Comments: JB$500x 40kf(7/5/64) cpv 5.80% zn 99.537, kqx 5.830%. Bpfpzxw H+140zpg. MOCw H+25zpg. Pzf Czqqw 6x;
Use of Proceeds
Ex cqxk tuq tqxkqk xccqk ixk kqmid kqlt

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research